This is premium content. Please become a Premium member. If you are already a member, login here to access the full content.
Biotech’s Cancer Test Not Exempt from GST: Maharashtra AAR
Case Law Details
- Case Name
- In re Epigeneres Biotech Private Limited (GST AAR Maharashtra)
- Appeal Number
- Only available for paid members
- Date of Judgement/Order
- Only available for paid members
- Courts
- AAR Maharashtra, Advance Rulings
Upgrade to Basic or Premium to download.
Already Upgraded? Log in.
In re Epigeneres Biotech Private Limited (GST AAR Maharashtra)
The Maharashtra Authority for Advance Ruling (AAR) has determined that the cancer prognostic and diagnostic services provided by Epigeneres Biotech Private Limited do not qualify for exemption from Goods and Services Tax (GST) under Entry No. 74 of Notification No. 12/2017-Central Tax (Rate). The AAR ruled that the applicant’s algorithm-based technology for early cancer detection, which involves blood tests and next-generation sequencing data analysis, is currently in the realm of research and development rather than a valida...





